Used as a key intermediate in the synthesis of antiviral agents, particularly in the development of hepatitis C virus (HCV) inhibitors. Its structure supports the formation of nucleoside analogs that interfere with viral replication. The presence of the nitro group and the oxetane ring enhances binding affinity to target enzymes, improving drug potency. Commonly employed in medicinal chemistry for optimizing pharmacokinetic properties in drug candidates.